Mer­ck is ‘well-po­si­tioned’ on Keytru­da ahead of threat­ened phar­ma tar­iffs, CEO says

Mer­ck CEO Rob Davis told in­vestors on Thurs­day that he’s con­fi­dent in the com­pa­ny’s abil­i­ty to pro­tect its top-sell­ing prod­uct from the po­ten­tial im­pacts of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER